1. Academic Validation
  2. A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429)

A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429)

  • J Med Chem. 1994 Apr 1;37(7):897-906. doi: 10.1021/jm00033a006.
W R Schoen 1 J M Pisano K Prendergast M J Wyvratt Jr M H Fisher K Cheng W W Chan B Butler R G Smith R G Ball
Affiliations

Affiliation

  • 1 Department of Basic Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065.
Abstract

The 3-substituted benzazepinone, L-692,429 (compound 1), is the prototype compound of a novel class of compounds that stimulate release of growth hormone (GH). The molecule evolved from efforts to identify a non-peptide mimic of the growth hormone-releasing hexapeptide, GHRP-6. Compound 1 is prepared by sequential attachment of dimethyl-beta-alanine and 2'-biphenylyltetrazole side chains to a chiral 3-aminobenzolactam nucleus. Comparison of the biological activity of 1 with the corresponding six- and eight-membered lactam analogs shows the seven-membered benzazepinone skeleton to be preferred. Molecular modeling of the structurally diverse GH secretagogues, L-692,429 and GHRP-6, was performed.

Figures